antineoplaston a10 has been researched along with epirubicin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abnous, K; Danesh, NM; Ramezani, M; Sarreshtehdar Emrani, A; Tabrizian, K; Taghdisi, SM; Zandkarimi, M | 1 |
1 other study(ies) available for antineoplaston a10 and epirubicin
| Article | Year |
|---|---|
Targeted delivery of Epirubicin to cancer cells by PEGylated A10 aptamer.
Topics: Antigens, Neoplasm; Antineoplastic Agents; Aptamers, Nucleotide; Benzeneacetamides; Cell Line, Tumor; Cell Survival; Drug Delivery Systems; Epirubicin; Humans; Male; Piperidones; Polyethylene Glycols; Prostatic Neoplasms | 2013 |